War wounded at risk for superbugs

Soldiers who survive severe injuries on battlefields such as those in Iraq and Afghanistan can be at risk from developing infections of their wounds with multidrug resistant bacteria.

The potentially lethal microbes include superbugs such as methicillin resistant Staphylococcus aureus (MRSA), Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella species and Escherichia coli.

Dr Clinton K. Murray, from Brooke Army Medical Center, USA, told the Society for General Microbiology Meeting at the International Centre, Harrogate, that at the beginning of the 20th century improved military hygiene and disease control led to a steady decline in the number of wartime deaths attributable to infections classically known as war pestilence, which included cholera, dysentery, plague, smallpox, typhoid, and typhus fever.

The development of more effective personal protective equipment, as well as training medics to provide life-saving procedures on the battlefield, has greatly improved survival rates, said Dr Murray. Positioning surgical and advanced medical care nearer to the point of injury has also enabled casualties to survive near-catastrophic wounds. But even though combat casualties are surviving these severe injuries, they risk developing wound infections. Microbes on the casualtys skin can be introduced into the wound at the time of injury or during subsequent medical care.

Although most of the infections can be treated with standard antibiotics, some of them may be caused by pathogens resistant to many if not all of these drugs. This requires clinicians to prescribe less commonly used antibiotics such as colistin. Modern microbiology and antimicrobial agents can do a lot but hospital infection control even in a war zone is of essential importance.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Modified darobactin offers hope for combatting antibiotic-resistant bacteria